Seasoned executive joins PrecisionLife to drive commercial strategy for new first-in-class precision medicine tests to predict and prevent complex, chronic diseases
Applications are invited for an Alliance and Impact Manager to join the Business Development department at Quadram Institute Bioscience (QIB), based in Norwich, UK.
Background:
Location: Nottingham, UK
Read One Nucleus' eNews January issue here
With Tony Jones, One Nucleus' CEO, guiding you on your journey to success in 2025, by signposting you to:
✅ Will Your 2025 Get Off to a Flying Start?
✅ Money: Investment, Partnering & Business Development
✅ People
✅ Technology
✅ Reflections on Genesis 2024
✅ One Nucleus Annual Awards
Trigeminal neuralgia, a chronic pain disorder rooted in trigeminal nerve dysfunction, presents a substantial challenge due to its intense pain profile and the limited effectiveness of current treatments.
This webinar offer enables researchers to expand their knowledge of ion channel therapeutics, develop innovative strategies, and accelerate the development of new, more effective treatments for patients burdened by chronic trigeminal pain.
Cambridge, UK, 25 November 2024: Metrion Biosciences (“Metrion”), the specialist preclinical contract research organisation (CRO) and a leader in ion channel screening, today announced the appointment of Lee Patterson as its new CEO, effective from 2nd December 2024. An experienced life sciences and CRO executive, Lee will guide the Company as it seeks to execute an ambitious growth strategy, enhancing its specialist services and expanding further in key global markets. He succeeds Dr Andrew Southan, who has decided to step down as CEO after five years in the post.
Biotechgate Digital Partnering is an online event that runs four times a year to support the business development & licensing of Pharma, Biotech, Medtech and Digital Health companies. Biotechgate Digital Partnering usually hosts over 1,000 representatives from leading life science companies and investors from around the globe, including big pharma, biotech start-ups and corporate investors.
The next edition of the popular five-day international conference series will be held from February 17 to 21, 2025, and is free to attend.
Boyds is looking for experienced, enthusiastic and motivated regulatory affairs professionals to join our award-winning regulatory team and support the future growth of our busy regulatory consultancy, working across a range of product types and therapeutic indications in the UK, EU and US.
As a Senior Director working alongside the Vice President of Regulatory Affairs, you will use your existing skills and knowledge to lead projects for clients from candidate selection to nonclinical and clinical development and to marketing authorization and beyond.
Boyds is looking for experienced, enthusiastic and motivated regulatory and medical writers to join our medical writing team. Working as part of the medical writing team, the successful candidates will be supporting the Boyds’ regulatory affairs, clinical operations and medical affairs teams across a range of projects, and directly with clients for standalone medical writing projects.
Role responsibilities:
Pioneer Group has today announced a collaboration agreement with Thermo Fisher Scientific to support biotech founders on their journey towards commercialising intellectual property in the healthcare and sustainability sectors.